About Access Genomics
Access Genomics is a company based in Mississauga (Canada) founded in 2016 was acquired by Igenomix in December 2020. Access Genomics operates in a competitive market with competitors including Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
- Headquarter Mississauga, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Access Genomics
Detailed funding history for Access Genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Access Genomics
Access Genomics has secured backing from 1 investor. Prominent investors backing the company include Igenomix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Reproductive genetic testing services are provided by the medical laboratory.
|
Locked | Locked | Locked |
Investor details for Access Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Access Genomics
Investment portfolio details for Access Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Access Genomics
Detailed financials for Access Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Access Genomics Comparisons
Peer comparison for Access Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Access Genomics
Access Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
Detailed competitors of Access Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Access Genomics
Complete news archive for Access Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Access Genomics
Access Genomics was founded in 2016.
Access Genomics is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Access Genomics was founded in 2016 and is based in Mississauga, Canada. Operations focus on the genomics sector, where services in molecular biology, embryology, and diagnostic screening are offered. Products include Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Non-Invasive Prenatal Testing (NIPT) for detecting trisomies 21, 18, and 13, as well as select sex chromosome aneuploidies. Genetic counselling services are also provided to support clinical applications.
Access Genomics's top competitors include Natera, ImaginAb and Lantern Pharma.
Access Genomics has 1 investor. Key investors include Igenomix.